SCHEMBL3938657

SCHEMBL3938657

CCCCCCCCC#CCCCCC/C=C/C(=O)O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.57
HMGCR P04035 4/20 0.56
PTPN7 P35236 3/20 0.55
PPARG P37231 2/20 0.51
PPARA Q07869 2/20 0.51
RECQL P46063 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX15 P16050 1/20 0.50
APEX1 P27695 1/20 0.50
CYP2C19 P33261 1/20 0.50
BLM P54132 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
HSD17B10 Q99714 1/20 0.50
DUSP3 P51452 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9983182 1.00 PTPN1 (0.57) PTPN1HMGCRPTPN7PPARGPPARA
SCHEMBL3938661 1.00 PTPN1 (0.57) PTPN1HMGCRPTPN7PPARGPPARA
SCHEMBL29460064 1.00 PTPN1 (0.57) PTPN1HMGCRPTPN7PPARGPPARA
SCHEMBL9983184 1.00 PTPN1 (0.57) PTPN1HMGCRPTPN7PPARGPPARA
SCHEMBL23116328 0.89 PTPN1 (0.68) PTPN1PTPN7PPARGPPARARECQL
SCHEMBL23116360 0.89 PTPN1 (0.68) PTPN1PTPN7PPARGPPARARECQL
SCHEMBL23116356 0.89 PTPN1 (0.68) PTPN1PTPN7PPARGPPARARECQL
SCHEMBL23116320 0.89 PTPN1 (0.68) PTPN1PTPN7PPARGPPARARECQL
SCHEMBL23802594 0.89 PTPN1 (0.68) PTPN1PTPN7PPARGPPARARECQL
SCHEMBL23116282 0.89 PTPN1 (0.68) PTPN1PTPN7PPARGPPARARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11952581-B2 Process for the production of polyunsaturated fatty acids in transgenic organisms BASF PLANT SCIENCE GMBH (DE) 2024-04-09 US disclosed
EP-2166069-B2 Method for producing polyunsaturated fatty acids in transgenic organisms BASF PLANT SCIENCE GMBH (DE) 2024-01-24 EP disclosed
US-20220213497-A1 Oils, Lipids and Fatty Acids Produced in Transgenic Brassica Plant BASF PLANT SCIENCE GMBH (DE) 2022-07-07 US disclosed
US-20220162629-A1 Process for the Production of Polyunsaturated Fatty Acids in Transgenic Organisms BASF PLANT SCIENCE GMBH (DE) 2022-05-26 US disclosed
US-20220056423-A1 PROCESSES FOR PRODUCING POLYUNSATURATED FATTY ACIDS IN TRANSGENIC ORGANISMS BASF PLANT SCIENCE GMBH (DE) 2022-02-24 US disclosed
US-20200054057-A1 USE OF ACETYLENIC FATTY ACID COMPOUNDS AS KOKUMI FLAVOR TAKASAGO INTERNATIONAL CORPORATION (JP) 2020-02-20 US disclosed
EP-3398442-A1 USE OF ACETYLENIC FATTY ACID COMPOUNDS AS KOKUMI FLAVOR Takasago International Corporation (JP) 2018-11-07 EP disclosed
EP-2046960-A1 PROCESS FOR PRODUCING ARACHIDONIC ACID AND/OR EICOSAPENTAENOIC ACID IN PLANTS BASF Plant Science GmbH (DE) 2009-04-15 EP disclosed
EP-1991684-A1 METHOD FOR PRODUCING POLYUNSATURATED FATTY ACIDS BASF Plant Science GmbH (DE) 2008-11-19 EP disclosed
WO-2008104559-A1 METHOD FOR THE PRODUCTION OF POLYUNSATURATED FATTY ACIDS IN TRANSGENIC ORGANISMS NORDDEUTSCHE PFLANZENZUCHT (DE) 2008-09-04 WO disclosed
WO-2008009600-A1 PROCESS FOR PRODUCING ARACHIDONIC ACID AND/OR EICOSAPENTAENOIC ACID IN PLANTS BASF PLANT SCIENCE GMBH (DE) 2008-01-24 WO disclosed
WO-2007096387-A1 METHOD FOR PRODUCING POLYUNSATURATED FATTY ACIDS BASF PLANT SCIENCE GMBH (DE) 2007-08-30 WO disclosed
EP-1769074-A2 METHOD FOR INCREASING THE CONTENT OF POLYUNSATURATED LONG-CHAINED FATTY ACIDS IN TRANSGENIC ORGANISMS BASF Plant Science GmbH (DE) 2007-04-04 EP disclosed
WO-2006008099-A2 METHOD FOR INCREASING THE CONTENT OF POLYUNSATURATED LONG-CHAINED FATTY ACIDS IN TRANSGENIC ORGANISMS BASF PLANT SCIENCE GMBH (DE) 2006-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220056423-A1 PROCESSES FOR PRODUCING POLYUNSATURATED FATTY ACIDS IN TRANSGENIC ORGANISMS ELOVL3, ELOVL1, ELOVL5 PTPN1 3940/4885HMGCR 522/4885PTPN7 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.